Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Douglas R. Adkins, Evisa Gjini et al.|Clinical Cancer Research|2020

Cited by 368